G., Fuglsang, H., Rosenberg, J., & Ismail Ggenur
Semaglutide works by acting like a natural gut hormone released after eating
For many patients, there is a transition: Phase 1: Correct Improve insulin resistance Reduce inflammation Initiate weight loss Phase 2: Stabilize Support muscle and metabolism Begin lowering the dose Phase 3: Maintain / Optimize Lower-dose or microdosing approach (when appropriate) Focus on long-term metabolic health At lower doses, GLP-1 medications may continue to support the bodynot just for weight loss, but for overall metabolic function
Now, things feel much more balanced for Ms Lily and she can live a relatively normal life as before
If you or your supplier is still using K0553 or K0554 for CGM claims in 2026, those claims will be denied
OBM Geriatrics (2020) 4(2):65